{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-000681","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2025-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.315715+00:00","generated_at":"2026-05-27T15:43:56.469580+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Dermata raises $2.55M private placement at $1.27/unit with insider participation","bullets":["Gross proceeds $2.55M; net ~$2.4M from 2,007,880 shares (or pre-funded warrants) and same number of warrants.","Warrants exercisable at $1.27/share upon stockholder approval and expire five years later.","Insiders (CEO, CFO, board) purchased ~$1.55M of offering at same $1.27/unit price.","Net proceeds plus cash expected to fund operations into Q3 2025.","H.C. Wainwright served as placement agent; resale registration statement to be filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-000681","json":"https://secwatch.observer/filing/0001654954-25-000681.json","markdown":"https://secwatch.observer/filing/0001654954-25-000681.md","text":"https://secwatch.observer/filing/0001654954-25-000681.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000165495425000681/0001654954-25-000681-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000165495425000681/drma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T15:43:56.469580+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}